Latest filing published 22 Dec 2020 for GenMark Diagnostics, Inc., €184k. Read the official filing
This profile gathers the share dealings of Alan Baer Maderazo in GenMark Diagnostics, Inc. We count 14 filings; the first trade dates from 19 May 2020 and the latest from 21 December 2020.
Every open-market trade on record is a sale: 11 sales worth €1.2M. The rest of the record consists of 3 option exercises.
Most recently, on 22 December 2020, the filings show an open-market sale worth €184k in GenMark Diagnostics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations